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Introduction
Cronobacter is a genus of Gram-negative, facultative-
anaerobic, nonspore-forming, motile bacteria belonging 
to the Enterobacteriaceae family. At present, seven spe-
cies are known: Cronobacter sakazakii, C. malonaticus, 
C. dublinensis, C. muytjensii, C. turicensis, C. condimenti, 
and C. universalis (Iversen et al. 2007; Iversen et al. 2008; 
Joseph et al. 2012; Stephan et al. 2014). Except for C. con­
dimenti, all species of Cronobacter have been isolated 
from clinical specimens. The Cronobacter species of 
serious clinical significance are as follows: C. sakazakii, 
C. malonaticus, C. turicencis, and C. universalis. Other 
members of the genus (C. dublinensis, C. muytjensii, and 
C. condimenti) are primarily environmental commen-
sals with low clinical significance (Iversen et al. 2007; 
Kucerova et al. 2010; Holy et al. 2011; Holy et al. 2014; 
Holy and Forsythe 2014; Forsythe 2018). Cronobacter 
spp. are opportunistic pathogens that cause rare but 
life-threatening diseases such as meningitis, necrotizing 
enterocolitis, and bloodstream infections in neonates 
and infants. The infections caused by these bacteria are 
often severe with fatal health consequences. The lethality 
rate of meningitis in infants was estimated to be 41.9% 
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A b s t r a c t
Cronobacter spp. have been recognized as causative agents of various severe infections in pre-term or full-term infants as well as elderly 
adults suffering from serious underlying disease or malignancy. A surveillance study was designed to identify antibiotic resistance among 
clinical Cronobacter spp. strains, which were isolated from patients of two hospitals between May 2007 and August 2013. Altogether, 
52 Cronobacter spp. isolates were analyzed. Although MALDI-TOF mass spectrometry recognized all Cronobacter sakazakii and Crono­
bacter malonaticus strains, it could not identify Cronobacter muytjensii strain. Nevertheless, all strains were identified as Cronobacter spp. 
using multilocus sequence typing (MLST). Strains were tested against 17 types of antibiotics, using the standard microdilution method 
according to the 2018 European Committee on Antimicrobial Susceptibility Testing criteria. Three Cronobacter species were identified as 
C. sakazakii (n = 33), C. malonaticus (n = 18), and C. muytjensii (n = 1); all isolates were susceptible to all tested antibiotics. All strains were 
PCR-negative for blaTEM, blaSHV, and blaCTX-M β-lactamase genes, as well. Even though the results of this study showed that Cronobacter spp. 
isolates were pan-susceptible, continued antibiotic resistance surveillance is warranted.
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with death occurring within hours after the manifesta-
tion of symptoms (Willis et al. 1988; Friedemann 2009; 
Holy and Forsythe 2014). The surviving individuals 
usually develop irreversible sequelae including seri-
ous neurological complications such as quadriplegia 
and impaired mental development (Bowen and Braden 
2006). Infants up to two months of age, premature 
with low birth weight or immunocompromised new-
borns are at the highest risk for infection. Cronobacter 
spp. have also been recognized as causative agents of 
various infections in elderly adults suffering from seri-
ous underlying disease or malignancy (Dennison and 
Morris 2002; See at al. 2007).
Cronobacter spp. are naturally resistant to all macro- 
 lides, lincomycin, clindamycin, streptogramins, rifam- 
picin, fusidic acid, and fosfomycin. Infections caused 
by these bacteria are usually treated with various com-
binations of ampicillin, gentamicin, cefotaxime, and 
chloramphenicol (Muytjens et al. 1983; Biering et al. 
1989; Bar-Oz et al. 2001; Block et al. 2002). Cronobac­
ter spp. tend to be more sensitive to most antibiotics 
that are being used clinically to treat infections caused 
by Enterobacteriaceae, although resistance to ampicil-
lin has developed (Muytjens and van der Ros-van de 
Repe 1986). In 1980, all tested strains were susceptible 
to ampicillin, whereas in 2001, five cases of Cronobac­
ter infection in which one or more of the isolates were 
resistant to ampicillin and first- and second-generation 
cephalosporins were described (Farmer et al. 1980; Lai 
2011). Similarly, Block et al. (2002) reported that all 
Cronobacter isolates tested were β-lactamase positive. 
Caubilla-Barron et al. (2007) previously reported two 
neonatal deaths from extended-spectrum β-lactamase 
(ESBL)-encoding C. sakazakii strains in a retrospec-
tive study of the Cronobacter necrotizing enterocolitis 
and meningitis outbreak in the neonatal intensive care 
unit. Then, Stock and Weidemann (2002) studied some 
Cronobacter strains and found that all strains were sus-
ceptible to the tested β-lactams.
The β-lactamase activity in Cronobacter has been 
frequently reported by others (Pitout et al. 1997; Cau-
billa-Barron et al. 2007; Baldwin et al. 2009). In 1997, 
a low-level β-lactamase production in Cronobacter was 
detected by Pitout et al. (1997). In addition, Lai (2001) 
also reported that Cronobacter strains were resistant to 
ampicillin, cefazolin, and extended-spectrum penicil-
lin. Moreover, a recent study showed that about 10.2% 
of the Cronobacter strains were resistant to cefotaxime, 
which is one of the third-generation cephalosporins 
related to penicillin (Pan et al. 2014). Rising antimi-
crobial resistance is generally a public health concern, 
potentially leading to prolonged illness and a  higher 
risk of mortality.
The aim of this study was to examine over time 
the changes in antibiotic resistance of different Crono­
bacter spp. strains and to determine the suscepti bi lity 
of Cronobacter isolates from clinical samples to 17 types 
of antibiotics.
Experimental
Materials and Methods
Bacterial strains and cultivation. The 52 isolates 
were collected during a survey of Cronobacter spp. car-
riage in patients of two hospitals over the 6-year period 
from May 2007 to August 2013. All strains were isolated 
from clinical samples (Table I). Microorganisms were 
routinely cultivated on blood agar (Oxoid, UK) at tem-
perature of 37°C overnight.
Identification of Cronobacter spp. by MALDI-
TOF MS. Sample preparation. For the protein extrac-
tion three colonies of each microorganism grown 
overnight on blood agar plates at 37°C under aerobic 
conditions were picked and resuspended in 300 µl of 
water (Sigma-Aldrich, USA) in 1.5 ml tube (Eppen-
dorf, Germany). Then, 900 µl of absolute ethanol were 
added and mixed. The tubes were centrifuged twice at 
13 000 rpm for 2 min and the supernatant was removed. 
The pellet was kept for 15 min at room temperature. The 
pellet was then dissolved in 50 µl of 70% formic acid. 
Finally, an equal volume of acetonitrile was added to 
the mixture and the mixture was stirred and centri-
fuged at 13 000 rpm for 2 min. The mixture was then 
vortexed for 15 seconds. After this, 1 µl of the super-
natant was spotted eight times onto a MALDI target, 
followed by the addition of 1 µl of HCCA (alpha-cyano-
4-hydroxy-cinnamic acid made as saturated solution 
in 30% acetonitrile/0.1% trifluoroacetic acid) and 
allowed to dry at room temperature before MALDI-
TOF MS analysis. Immediately after drying, the spot 
was overlaid with 1 µl of matrix (Schulthess et al. 2016). 
MALDI-TOF MS measurements were performed 
with a microflex LT (Bruker Daltonics, Bremen, Ger-
many). Each spot was analysed in triplicate (24 spec-
tra in total). Each generated spectrum resulted from 
240 laser shots (40 laser shots at six multiple positions 
on the target spot). All investigations were perfor- 
med in triplicate.
Data analysis. The resulting 72 spectra were care-
fully analysed using the Flex Analysis (version  3.0, 
Bruker Daltonics, Germany) and subjected to smooth-
ing and baseline subtraction. Furthermore, at least 24 
spectra of each strain were used to create a single stand-
ard mass spectrum (MSP) with the default setting of the 
BioTyper MSP creation method. To visualize the differ-
ence between the strains, MSP dendrogram clustering 
was constructed using the standard settings in MALDI 
BioTyperTM software.
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C. sakazakii 1836 2.354 4 Wound swab
C. sakazakii 1837 2.432 4 Wound swab
C. sakazakii 1839 2.503 4
 Smear from area of percutaneous
    endoscopic gastrostomy
C. sakazakii 1840 2.452 4 Sputum
C. sakazakii 1841 2.444 4 Sputum
C. sakazakii 1842 2.409 4 Sputum
C. sakazakii 1901 2.467 4 Sputum
C. sakazakii 1902 2.421 4 Sputum
C. sakazakii 1903 2.487 4 Sputum
C. sakazakii 1915 2.509 4 Sputum
C. sakazakii 1916 2.464 4 Sputum
C. sakazakii 1996 2.484 4 Sputum
C. sakazakii 1997 2.505 4 Sputum
C. sakazakii 1998 2.485 4 Sputum
C. sakazakii 2000 2.479 4 Rectal swab
C. sakazakii 2001 2.473 4 Swab of the oral cavity
C. sakazakii 2002 2.476 4 Sputum
C. sakazakii 2003 2.423 4 Sputum
C. sakazakii 2005 2.457 4 Sputum
C. sakazakii 2006 2.357 4 Sputum
C. sakazakii 2007 2.438 4 Sputum
C. sakazakii 2008 2.416 4 Sputum
C. sakazakii 2009 2.459 4 Tongue swab
C. sakazakii 2010 2.388 4 Throat swab
C. sakazakii 2011 2.417 4 Suction catheter
C. sakazakii 2012 2.494 4 Sputum
C. sakazakii 2013 2.451 4 Sputum
C. sakazakii 2021 2.446 4 Sputum
C. sakazakii 2016 2.448 4 Sputum
C. sakazakii 2017 2.510 4 Sputum
C. sakazakii 2019 2.367 4 Sputum
C. sakazakii 2022 2.426 4 Sputum
C. sakazakii 1995 2.508 64 Sputum
C. malonaticus 1826 2.313 7 Cannula
C. malonaticus 1827 2.293 7 Cannula
C. malonaticus 1828 2.419 7 Nose swab
C. malonaticus 1829 2.329 7 Throat swab
C. malonaticus 1830 2.429 7 Throat swab
C. malonaticus 1831 2.415 7 Throat swab
C. malonaticus 1832 2.373 7 Throat swab
C. malonaticus 1833 2.398 7 Stool - dissection
C. malonaticus 1834 2.345 7 Throat swab
C. malonaticus 1835 2.336 7 Throat swab
C. malonaticus 1914 2.426 7 Sputum
C. malonaticus 1917 2.387 7 Throat swab
C. malonaticus 1999 2.361 7 Throat swab
C. malonaticus 2004 2.343 7 Throat swab
Table I
Identification and genotyping of Cronobacter spp. isolated from clinical samples.
Strain Strain No. Log (score)* Sequence type Origin
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The linkage function was normalised according to 
the distance between 0 (perfect match) and 1 000 (no 
match). Species with distance levels under 500 have been 
described as reliably classified species (Sauer et al. 2008).
Following the creation of MSPs of strains, each 
MSP was identified. All spectra were imported into 
the Biotyper software and analyzed against the Bruker 
library. Identification scores of ≥ 2.0 have been declared 
by manufacturer as a reliable identification to the 
species level and scores of ≥ 1.7 but < 2.0 to the genus 
level if the conditions of species and genus consistency 
are fulfilled, respectively. Isolates with log-score above 
2.3 were used for dendrogram generation if the best 
three matches indicated the same species.
Multilocus sequence typing (MLST). The MLST 
scheme for the strains investigated was performed 
previously by Alsonosi et al. (2015) and published in 
the curated Cronobacter PubMLST open access data-
base (http://www.pubmlst.org/cronobacter). The seven 
housekeeping genes atpD (ATP synthase beta chain), 
fusA (elongation factor G), glnS (glutaminyl-tRNA syn-
thetase), gltB (glutamate synthase large subunit), gyrB 
(gyrase subunit B), infB (translation initiation factor 
IF-2), and ppsA (phosphoenolpyruvate synthase) were 
sequenced. The results obtained were compared with 
data at the Cronobacter PubMLST database.
Antimicrobial susceptibility testing. All Cronobac­
ter strains were tested for susceptibility against 17 types 
of antibiotics, that were: ampicillin, aztreonam, ampi-
cillin/sulbactam, gentamicin, piperacillin, tobramycin, 
piperacillin/tazobactam, amikacin, cefuroxime, cipro-
floxacin, cefotaxime, tigecycline, ceftazidime, colistin, 
cefepime, trimethoprim/sulfamethoxazole, and mero-
penem. The susceptibility to antibiotics was assessed 
by a standard microdilution method according to the 
European Committee on Antimicrobial Susceptibility 
Testing criteria 2018 (EUCAST 2018).
Detection of blaTEM, blaSHV, and blaCTX-M 
genes. The detection of blaTEM, blaSHV, and blaCTX­
M genes (encoding TEM, SHV, and CTX-M types of 
β-lactamases) was performed by PCR in all Cronobac­
ter spp. isolates examined. As positive controls, the 
following strains were used: Escherichia coli NCTC 
13400 (blaCTX­M-15), E. coli NCTC 13351(blaTEM-3) 
and Klebsiella pneumoniae NCTC 13368 (blaSHV-18). 
Total bacterial DNA was isolated from an overnight 
culture of the isolates (16 h, 37°C) grown on meat-
peptone agar. Two colonies were suspended in 100 μl 
of water and heated at 95°C for 10 min. After remov-
ing of cellular debris by centrifugation at 13 000 × g for 
2 min, the supernatant was used as a template DNA for 
amplification. Polymerase chain reaction with a specific 
set of primers was performed for the detection of genes 
that encode relevant beta-lactamases (Arlet et al. 1995; 
Chanawong et al. 2000; Pagani et al. 2003).
Results
Identification and typing of Cronobacter isolates. 
Bacterial strains were identified by the MALDI-TOF 
mass spectrometry and genotyped by MLST. The pro-
tein spectra of 52 isolates were compared with those 
included in MALDI BioTyperTM reference database. 
The matching of an unknown spectrum with that in 
reference database was quantified by the log-score. 
The protein spectra of 52 isolates were obtained from 
three independent assays. The logarithms of score val-
ues ≥ 2 were required for reliable identification of the 
unknown strains at the species level. The average val-
ues of the log-score fall within limits of 2.173 to 2.510 
(Table I). The most prevalent species recovered from 
clinical samples were C. sakazakii (n = 33; 63.5%) and 
C. malonaticus (n = 18; 34.6%). Only one strain was 
identified as Pantoea agglomerans (1.9%) – the strain 
No. 1838. However, this strain was subsequently reclas-
sified as C. muytjensii according to results of the MLST.
As we previously published, based on the MLST 
results for clinical strains, the intra-species diversity 
was poor. A majority of C. sakazakii strains (n = 32) 
belonged to the dominant sequence type 4, whereas 
only one C. sakazakii strain isolated from sputum was 
* Log (score) according to MALDI-TOF identification. According to the MALDI-TOF MS strain No. 1838 was 
identified as P. agglomerans.
 This strain was subsequently reclassified as C. muytjensii according to results of the MLST
C. malonaticus 2014 2.388 7 Throat swab
C. malonaticus 2015 2.353 7 Throat swab
C. malonaticus 2018 2.339 7 Sputum
C. malonaticus 2020 2.173 7 Stool
P. agglomerans/ 1838 2.358 28 SputumC. muytjensii
Table I. Continued.
Strain Strain No. Log (score)* Sequence type Origin
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determined as ST64. All C. malonaticus isolates were 
classified as ST7. Only C. muytjensii was assigned to 
ST28 (Alsonosi et al. 2015).
Antibiotic susceptibility. Antibiotic resistance 
profiling revealed that all 52 isolates were sensitive 
to ampicillin, aztreonam, ampicillin/sulbactam, gen-
tamicin, piperacillin, tobramycin, piperacillin/tazobac-
tam, amikacin, cefuroxime, ciprofloxacin, cefotaxime, 
tigecycline, ceftazidime, colistin, cefepime, trimetho-
prim/sulfamethoxazole, and meropenem. No resistant 
strains were found. The minimal inhibitory concentra-
tions of the antimicrobial mentioned above were given 
in Table II. The blaTEM, blaSHV, and blaCTX­M, β-lactamase 
genes in the genome of our isolates were not found in 
any Cronobacter species, as well.
Discussion
The Enterobacteriaceae family are often associated 
with hospital-acquired infections. The most vulnerable 
population consists of immunocompromised patients 
(Holy et al. 2012; Matouskova et al. 2012; Matouskova 
and Holy 2013; Matouskova and Holy 2014). Antimi-
crobial resistance is a public health concern because 
it may cause failure of conventional treatment, result-
ing in prolonged illness and a higher risk of mortality. 
Resistance among human pathogens of Enterobacte­
riaceae has direct clinical impact on patients due to 
longer treatment and hospitalization, need for more 
expensive drugs, and often fatal consequences. Thus, 
infections due to resistant Klebsiella spp., E. coli, and 
Enterobacter spp. are now known as a major problem 
associated with health-care associated infections. The 
Cronobacter genus has undergone an extensive diver-
sification during the course of its evolution, with some 
species clearly pathogenic for humans and other spe-
cies still with unknown or uncertain impact on human 
health. Unfortunately, information on the diversity, 
pathogenicity, and virulence of Cronobacter species 
obtained from various sources is still relatively scarce 
and fragmentary. Applying the MLST scheme on clini-
cal C. sakazakii strains revealed that the strains asso-
ciated with meningitis, bacteremia, undefined infec-
tion, or necrotizing enterocolitis in neonates, infants, 
and children belong to the predominant sequence type 
profile 4 (Joseph and Forsythe 2011; Hariri et al. 2013). 
Virulence-related traits have also been found through 
draft and complete genome sequencing of Cronobacter 
spp. (Bar-Oz et al. 2001; Stephan et al. 2014). In some 
studies, up to 50% of Cronobacter spp. infection in 
adults had underlying malignancy (Lai 2001).
Two distinct identification systems, MALDI-TOF 
mass spectrometry and MLST, were compared in this 
study. MALDI-TOF MS protein profiling, based on 
the protein spectra obtained from intact whole cells, 
cell lysates, or bacterial extracts, is now widely used 
as an instrumental technique for bacterial identifica-
tion. The main advantage of this analytical method, 
compared with other typing procedures, is its rapidity, 
low-cost requirements, and ease of use. Although the 
method usually provides the reliable discrimination 
of the common human pathogens (Barbuddhe et al. 
2008; Mellmann et al. 2008; Davies et al. 2012; Kuhns 
et al. 2012), the correct identification of unknown 
protein profiles depends on the size and precision of 
the default database. In our case, the majority of iso-
lates was reliably discriminated at the species level 
in congruence with results obtained via MLST. Only 
isolate 1838 was misidentified as Pantoea agglomer­
ans by MALDI-TOF MS. Further analysis by MLST 
resulted in a re-classification of this microorganism as 
C. muy tjensii, sequencing type 28 (Table I). An applica-
tion of at least two independent identification methods 
is therefore recommended to minimize the number of 
misidentified strains.
Multilocus sequence typing divided 52 clinical 
strains into three species and five sequencing types 
(Alsonosi et al. 2015, Table  I). Nearly all of the 33 
C. sakazakii were typed as neonatal ST4, and only one 
was classified as a neonatal ST64. The 18 C. malonaticus 
strains belonged to ST7, which is usually isolated and 
causes serious infections in neonates or adults. The spec-
trum of Cronobacter spp. and types is quite similar to 
those reported in previous studies (Joseph and Forsythe 
2011; Kadlicekova et al. 2018). Poor species and intra-
species diversity of the strains obtained from the clinical 
samples indicates that mucosa of human beings may be 
colonized by only limited Cronobacter sequence types.
Antimicrobial susceptibility was performed against 
17 antibacterial agents. It is known that the extensive 
use of antimicrobials in agriculture and health-care 
facilities has led to the emergence of resistant bacterial 
strains. Nonetheless, the present study has shown that 
all used clinical strains of Cronobacter were suscepti-
ble to 17 antimicrobial agents, which represent a broad 
spectrum of typical antibiotics for enterobacteria. Simi-
larly to these study findings, other studies have reported 
the susceptibility of Cronobacter strains to all antibiotics 
that were used in these studies (Terragno et al. 2009; 
Hochel et al. 2012; Vojkovska et al. 2016; Brandão et al. 
2017). In these studies, all Cronobacter strains were 
isolated from food sources or powered infant formula 
and mainly C. sakazakii was investigated. Therefore, 
our study is a unique one since it shows a susceptibil-
ity of clinical isolates of both species C. sakazakii and 
C. malonaticus. These two species have been found to 
be associated with several serious neonatal and adult 
infections (See et al. 2007; Healy et al. 2010; Asato et al. 
2013; Hariri et al. 2013; Brandão et al. 2017; Alsonosi 
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et al. 2018). As a part of the present study, β-lactamase 
genes, blaTEM, blaSHV, and blaCTX­M, were screened among 
Cronobacter isolates. The results were consistent with 
the results of susceptibility assays, as all strains were 
negative for β-lactamase genes. However, other stud-
ies have shown emergence of resistance to penicillin 
and extended-spectrum β-lactamases (Block et al. 
2002; Caubilla-Barron et al. 2007). Recently, two studies 
have shown that multi-drug resistance in Cronobacter 
is emerging through horizontal gene transfer mecha-
nisms (Cui et al. 2015; Shi et al. 2016). In addition, the 
excessive use of antibiotics in the hospital environment 
facilitates the possibility of emerging of a high level of 
antimicrobial resistance among clinical strains. There-
fore, the surveillance studies would assist in preven-
tion of the developing this phenomenon and in keeping 
Cronobacter susceptible to the majority of the available 
clinical antimicrobial agents.
Conclusions
A low level of antibiotic resistance among Cronobac­
ter spp. in our region is due to a good antibiotic usage 
policy. The minimizing of the occurrence of encepha-
litis, necrotizing enterocolitis, and septicemia among 
infants in the Czech Republic caused by Cronobac­ 
ter spp. is also due to the excellent hospital care. We 
were able to isolate only 52 strains during the 6-year 
period of our study, and the majority of them were iso-
lated from adults.
This study shows that although antimicrobial resist-
ance among Cronobacter spp. is not a big issue nowa-
days, many resistant cases among Cronobacter spp. have 
been reported worldwide. Increasing antimicrobial 
resistance is not only a clinical problem associated with 
health-care facilities, but it is also a big public health 
issue. Selection pressure plays a crucial role in their 
spreading not only in health care facilities but also in 
the environment (e.g., food chains and waste waters).
The authors are aware of the limitations associated 
with this study, especially of the low number of samples. 
On the other hand, the advantage is that these samples 
were collected over quite a long period of time.
No official breakpoints by EUCAST were estab-
lished for Cronobacter spp., only for Enterobacteriaceae 
in general, which is not sufficient. The epidemiological 
cut-off value (ECOFF) for Cronobacter spp. should be 
established in the near future.
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